An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab

Autor: Kennedy, Adam D., Solga, Michael D., Schuman, Theodore A., Chi, Amos W., Lindorfer, Margaret A., Sutherland, William M., Foley, Patricia L., Taylor, Ronald P. *
Zdroj: In Blood 1 February 2003 101(3):1071-1079
Databáze: ScienceDirect